(Q78427596)

English

Semicochliodinol A and B: Inhibitors of HIV-1 Protease and EGF-R Protein Tyrosine Kinase Related to Asterriquinones Produced by the Fungus Chrysosporium merdarium.

scientific article published on 01 March 2012

In more languages

Statements

scholarly article

1 reference

10.7164/ANTIBIOTICS.50.395

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.395

14 December 2019

Semicochliodinol A and B: Inhibitors of HIV-1 Protease and EGF-R Protein Tyrosine Kinase Related to Asterriquinones Produced by the Fungus Chrysosporium merdarium. (English)

1 reference

10.7164/ANTIBIOTICS.50.395

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.395

14 December 2019

Chrysosporium merdarium

1 reference

semicochliodinol B

1 reference

Didemethylasterriquinone D

1 reference

Didemethylasterriquinone D

1 reference

Asterriquinone CT3

1 reference

semicochliodinol A

1 reference

author name string

ANDREAS FREDENHAGEN

1

1 reference

10.7164/ANTIBIOTICS.50.395

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.395

14 December 2019

FRANK PETERSEN

2

1 reference

10.7164/ANTIBIOTICS.50.395

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.395

14 December 2019

MARINA TINTELNOT-BLOMLEY

3

1 reference

10.7164/ANTIBIOTICS.50.395

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.395

14 December 2019

JOHANNES RÖSEL

4

1 reference

10.7164/ANTIBIOTICS.50.395

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.395

14 December 2019

HELMUT METT

5

1 reference

10.7164/ANTIBIOTICS.50.395

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.395

14 December 2019

PAUL HUG

6

1 reference

10.7164/ANTIBIOTICS.50.395

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.395

14 December 2019

publication date

1997

3 references

16 September 2022

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/antibiotics1968/50/5/50_5_395/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.50.395?email=unpaywall_01@example.com

The Journal of Antibiotics

1 reference

10.7164/ANTIBIOTICS.50.395

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.395

14 December 2019

50

1 reference

10.7164/ANTIBIOTICS.50.395

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.395

14 December 2019

5

1 reference

10.7164/ANTIBIOTICS.50.395

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.395

14 December 2019

395-401

1 reference

10.7164/ANTIBIOTICS.50.395

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.395

14 December 2019

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.50.395?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/IJC.2910430519

Large-scale purification and characterisation of a recombinant epidermal growth-factor receptor protein-tyrosine kinase. Modulation of activity by multiple factors

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.395

Comparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with CGP 53820, a novel pseudosymmetric inhibitor

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.395

Antitumor activity of asterriquinones from Aspergillus fungi. IV. An attempt to modify the structure of asterriquinones to increase the activity

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.395

Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.395

Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.395

Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.395

Identifiers

10.7164/ANTIBIOTICS.50.395

1 reference

10.7164/ANTIBIOTICS.50.395

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.50.395

14 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q78427596&oldid=2127261047"